Journal: JCI Insight
Article Title: Autoimmune inner ear disease patient–associated 28-kDa proinflammatory IL-1 β fragment results from caspase-7–mediated cleavage in vitro
doi: 10.1172/jci.insight.130845
Figure Lengend Snippet: Expression levels of (A) IL-1β, (B) IL-6, (C) CCL3, (D) MMP-9, (E) TIMP-1, and (F) TNF-α mRNA from PBMCs of patients with AIED (n = 9) and controls (n is shown for each panel) treated with 1 μg/mL LPS (positive control); recombinant IL-1β (rIL-1β) (Peprotech); or 17-kDa, 28-kDa, and 31-kDa (negative control) fragments of IL-1β or left untreated. The expression levels were measured in replicate samples by real-time quantitative PCR (qPCR) using 480 LightCycler. Data shown are mean ± SEM. The threshold cycle (Ct) value was calculated from amplification plots, and gene expression was normalized using the Ct of the housekeeping gene glyceraldehyde-3-phosphate. Fold induction of the target gene was calculated using the formula 2−ΔΔCt. Statistical significance was achieved for the difference in expression for IL-1β in response to the 28-kDa and 17-kDa fragments in control subjects (P = 0.016). Although differences were observed between expression in response to the 28-kDa and 17-kDa fragments for IL-6 and CCL3, these did not achieve significance. MMP-9 and TNF-α expression showed minimal, insignificant changes in response to the IL-1 fragments. The Wilcoxon signed-rank test was performed for paired observations, to compare expression levels within groups, in response to the 17-kDa and 28-kDa fragments. For the pairwise comparison of 17-kDa and 28-kDa fragments, a Bonferroni’s adjustment was made for the 2 hypothesis tests carried out within a cytokine. The 2 tests were carried out comparing 17-kDa and 28-kDa fragments within the AIED group and within the control group, such that any given comparison required P < (0.05 / 2) = 0.025. Each experiment was repeated twice to confirm reproducibility.
Article Snippet: After brief centrifugation, cell culture supernatant samples were analyzed using human IL-1β, IL-6, CCL3, TNF-α, TIMP-1, MMP-9, and IL-4 ELISA kits (all from R&D Systems) according to the manufacturer’s instructions.
Techniques: Expressing, Positive Control, Recombinant, Negative Control, Real-time Polymerase Chain Reaction, Amplification, Comparison